Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

CRO/CMO Services

The following articles are focused on China Contract Research Organizations (CROs) and Contract Manfacturing Organizations (CMOs) offering both clinical and pre-clinical services.  Included are news, deals and company information.

ZhenGe Biotech Completes $51 Million A Round for CDMO Operations

Shanghai OPM Bio Raises $14 Million for Biologic CDMO Service Platform

Invetx Raises $15 Million from Anterra, AbCellear and WuXi Biologics

WuXi Vaccines Signs $3 Billion, 20-Year Agreement to Manufacture Vaccine

Celltrion Plans $513 Million Wuhan Biologics Facility; 18 Biologic Launches in China by 2030

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China